A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs

Clinical trial NCT01209702 · TERMINATED

Trial details

NCT number: NCT01209702
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Spondylitis, Ankylosing

Start date: 2010-09-01
Primary completion: 2011-05-01
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.